✦ LIBER ✦

Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment

✍ Scribed by Jambur Ananth; Kamala Aduri; Sharath Parameswaran; Sarath Gunatilake

Book ID: 110755972
Publisher: John Wiley and Sons
Year: 2004
Tongue: Dutch
Weight: 139 KB
Volume: 16
Category: Article
ISSN: 0924-2708
DOI: 10.1111/j.0924-2708.2004.00085.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical risk factors for neuroleptic ma

Clinical risk factors for neuroleptic malignant syndrome

✍ Domenico Berardi; Maddalena Dell'Atti; Mario Amore; Diana De Ronchi; Giuseppe Fe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

Pharmacological risk factors for neuroleptic malignant syndrome (NMS) are better defined than clinical risk factors. We examined the psychopathological status preceding the onset of NMS in 20 patients. We evaluated four key psychiatric symptoms (psychomotor agitation, catatonia, disorganization and

Catatonia and neuroleptic malignant synd

Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology

✍ G. Northoff 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 110 KB

Postpartum Period: A Risk Factor for Neu

Postpartum Period: A Risk Factor for Neuroleptic Malignant Syndrome

✍ A. A. Fido 📂 Article 📅 1999 🏛 American Academy of Clinical Psychiatrists 🌐 English ⚖ 234 KB

Neuroleptic Malignant Syndrome during Pe

Neuroleptic Malignant Syndrome during Perphenazine Treatment

✍ Nielsen, Dorthe ;Aunsholt, Niels Aage ;Andersen, Per Thorgaard 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Neuroleptic–malignant syndrome

✍ J.W. Mackenzie 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Neuroleptic–malignant syndrome

✍ Anne E. Peebles-Brown 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB